| s_id |
sentence |
| 5540 |
In a research note published this morning, the analysts mention that the company is expected to witness stiff competition in the forthcoming twelve months. |
| 8251 |
In a research note published this morning, the analyst mentions that the Phase III trial results of the company's Oncophage product are likely to be negative. |
| 11734 |
In a research note published this morning, the analysts mention that the company has reduced its sales guidance for FY04 from ¥905 billion to ¥840 billion on account of the delay in new products and music software. |
| 20782 |
In a research note published this morning, the analyst mentions that the company's non-GAAP EPS for 4Q05 declined 50% y/y and 59% q/q. |
| 26526 |
In a research note published this morning, the analyst mentions that smaller ERP vendors are witnessing significant revenue erosion and pricing pressures, since the large vendors are expanding SCM functionality. |
| 33536 |
In a research note published this morning, the analysts mention that there is low visibility into numerous operational metrics at the company. |
| 54470 |
In a research note published this morning, the analysts mention that the company is reviewing the dual listing of the group's PLC segment in the UK and its NV segment in the Netherlands. |
| 60226 |
In a research note published this morning, the analyst mentions that the company has recently received two subpoenas, which are likely to impact its future financial metrics. |
| 65671 |
In a research note published this morning, the analysts mention that the company has presented the latest data for the studies conducted on Byetta at the meeting of the American Diabetes Association. |
| 71176 |
In a research note published this morning, the analyst mentions that the company reported robust results for the previous quarter, with 20% revenue growth. |
| 71304 |
In a research note published this morning, the analysts mention that the downgrade is based on valuation, since the company's share price has reached the target price. |
| 79619 |
In a research note published this morning, the analysts mention that the company is well-positioned to benefit from the evolution of the dosage form contract manufacturing market. |
| 81612 |
In a research note published this morning, the analyst mentions that the company's risk/reward profile is more balanced at present. |
| 83112 |
In a research note published this morning, the analysts mention that the company has reported robust results for the last quarter, reflecting 9.6% growth in new orders. |
| 85384 |
In a research note published this morning, the analysts mention that the company is likely to report its Q3 comps at -3%. |
| 91367 |
In a research note published this morning, the analyst mentions that the company has raised its Q1 and 2005 guidance on account of improved operating performance in its printed-products division. |